In Burkitt lymphoma, mantle cell lymphoma, follicular lymphoma, and chronic lymphocytic leukemia or acute lymphoblastic leukemia, FoxO1 exhibits a key oncogenic character that allows cell survival, suggesting the possibility of its therapeutic targeting. Here, FOXO1 is linked to acute lymphoblastic leukemia.